Skip to main content
Clinical Trials/NCT02296450
NCT02296450
Recruiting
Not Applicable

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Memorial Sloan Kettering Cancer Center3 sites in 1 country1,025 target enrollmentNovember 18, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
1025
Locations
3
Primary Endpoint
Quality of Life (QoL) questionnaire
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times, these conditions are a side effect of cancer treatment. Patients in the study will be asked to fill out at least one questionnaire about how they feel about their skin condition. If the patient needs to be treated for their skin condition, they will be asked to complete the same questionnaire when they return for a follow-up visit. The investigators hope the study will improve our understanding of how cancer patients feel about their skin conditions. They also hope this study helps them learn how to improve the way we treat skin conditions in cancer patients.

Registry
clinicaltrials.gov
Start Date
November 18, 2014
End Date
November 1, 2026
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cancer patients and survivors with a pre-existing dermatologic condition related to their underlying disease or completed/ongoing therapy for cancer, who present for assessment/management of their skin condition.
  • Male or female patients at least 3 years and older
  • NOTE: Informed Consent guidelines will be followed for minors
  • First grade adult family members, spouses, and caregivers of patients with a Grade 2 or 3 or higher dermatologic condition related to their primary cancer or cancer treatment able to provide written informed consent

Exclusion Criteria

  • Cognitive or psychiatric deficit resulting in an inability to provide written informed consent

Outcomes

Primary Outcomes

Quality of Life (QoL) questionnaire

Time Frame: 5 years

in cancer patients and survivors with dermatologic conditions. This is a nontherapeutic and nondiagnostic protocol to obtain quality of life assessments from cancer patients and survivors who have dermatologic conditions, whether related to cancer therapies, or directly related to the primary cancer diagnosis. Data will be collected by using one or more dermatology-specific QoL instruments based on the underlying skin condition/s.

Study Sites (3)

Loading locations...

Similar Trials